Cargando…

Burden of carbapenem non-susceptible infections in high-risk patients: systematic literature review and meta-analysis

BACKGROUND: Owing to their resistance to an important class of antibiotics, the prevention and treatment of carbapenem-resistant (CR)/non-susceptible Gram-negative (GN) infections has become an important public health objective. We conducted a systematic review and meta-analysis of published literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avendano, Esther E., Raman, Gowri, Chan, Jeffrey, McCann, Eilish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720068/ https://www.ncbi.nlm.nih.gov/pubmed/33287894 http://dx.doi.org/10.1186/s13756-020-00858-8

Ejemplares similares

Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections
por: Tabak, Ying P., et al.
Publicado: (2020)

Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Respiratory Infections
por: McCann, Eilish, et al.
Publicado: (2020)

Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections
por: McCann, Eilish, et al.
Publicado: (2020)

517. Treatment Patterns of Hospitalized Adults with Infections Due to Carbapenem Non-Susceptible Gram-Negative Organisms in a Large Electronic Health Record Database in the United States
por: Burton, Tanya, et al.
Publicado: (2019)

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
por: Raman, Gowri, et al.
Publicado: (2018)

Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis
por: Raman, Gowri, et al.
Publicado: (2015)

Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis
por: Ponce de Leon, Alfredo, et al.
Publicado: (2020)

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
por: McCann, Eilish, et al.
Publicado: (2018)

Effects of Intake of Apples, Pears, or Their Products on Cardiometabolic Risk Factors and Clinical Outcomes: A Systematic Review and Meta-Analysis
por: Gayer, Bridget A, et al.
Publicado: (2019)

Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
por: Ferrer, Ricard, et al.
Publicado: (2021)

Dietary intakes of flavan-3-ols and cardiometabolic health: systematic review and meta-analysis of randomized trials and prospective cohort studies
por: Raman, Gowri, et al.
Publicado: (2019)

The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysis
por: Al-Dakkak, Imad, et al.
Publicado: (2012)

Therapeutic Management of Pseudomonas aeruginosa Bloodstream Infection Non-Susceptible to Carbapenems but Susceptible to “Old” Cephalosporins and/or to Penicillins
por: Zaidenstein, Ronit, et al.
Publicado: (2018)

2269. Clinical Outcomes in Patients with Carbapenem-Non-Susceptible, β-Lactam-Susceptible Pseudomonas aeruginosa Infections
por: Gavaghan, Victoria M, et al.
Publicado: (2019)

Potato consumption and risk of cardio-metabolic diseases: evidence mapping of observational studies
por: So, Jisun, et al.
Publicado: (2020)

Treatment of Piperacillin-Tazobactam–Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials
por: Cao, John, et al.
Publicado: (2023)

A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections
por: Shi, Qingyi, et al.
Publicado: (2019)

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Zhu, Yunying, et al.
Publicado: (2021)

Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae
por: Bartolini, Andrea, et al.
Publicado: (2014)

Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France
por: Jeannot, Katy, et al.
Publicado: (2014)

Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Optimized β-Lactam Therapy Improves Survival in Carbapenem Non-Susceptible Gram-Negative Infections
por: Flynt, Lauren K, et al.
Publicado: (2017)

716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
por: Clark, Justin A, et al.
Publicado: (2023)

Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria
por: Meradji, Samah, et al.
Publicado: (2015)

485. Clinical and Molecular Epidemiology of Carbapenem Non-susceptible Citrobacter sp.
por: Babiker, Ahmed, et al.
Publicado: (2019)

Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital
por: Cubero, Meritxell, et al.
Publicado: (2015)

1490. Serious Infections Caused by Carbapenem Susceptible and Carbapenem Resistant Acinetobacter baumannii-calcoaceticus Complex - A Retrospective Review
por: Rana, Khurram, et al.
Publicado: (2020)

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
por: Nathwani, Dilip, et al.
Publicado: (2014)

Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit
por: Pace, Maria Caterina, et al.
Publicado: (2023)

Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data
por: Black, Christopher M., et al.
Publicado: (2016)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
por: Clark, Justin, et al.
Publicado: (2021)

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae
por: Armin, Shahnaz, et al.
Publicado: (2023)

Multicenter Study of the Risk Factors and Outcomes of Bloodstream Infections Caused by Carbapenem-Non-Susceptible Acinetobacter baumannii in Indonesia
por: Anggraini, Dewi, et al.
Publicado: (2022)

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016)

Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
por: Xu, Liangfei, et al.
Publicado: (2017)

Dietary intakes of flavan-3-ols and cardiovascular health: a field synopsis using evidence mapping of randomized trials and prospective cohort studies
por: Raman, Gowri, et al.
Publicado: (2018)

The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital
por: Tangsawad, Watcharaphon, et al.
Publicado: (2022)

Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa
por: Gill, Christian M, et al.
Publicado: (2022)

Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptibleEscherichia colibloodstream infection
por: Xie, Ouli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_smc53evv6nr9nuts6sm7g175bq